Clinical Trials · NCT06180616
Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Royal North Shore Hospital
- Enrollment
- 40
- Start date
- Dec 2026
- Locations
- See registry
- Primary endpoint
- Body weight